Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3 : partial characterization of the inhibitory epitope and potential applications
about
Purinergic signalling in endocrine organsCystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3Epitope mapping in cell surface proteins by site-directed masking: defining the structural elements of NTPDase3 inhibition by a monoclonal antibody.Purine-metabolizing ectoenzymes control IL-8 production in human colon HT-29 cells.Histamine induces ATP release from human subcutaneous fibroblasts, via pannexin-1 hemichannels, leading to Ca2+ mobilization and cell proliferation.Ectonucleotidases in the kidney.Generation and Characterization of Specific Antibodies to the Murine and Human Ectonucleotidase NTPDase8.Neuromodulation: purinergic signaling in respiratory control.Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.Generation and characterization of polyclonal and monoclonal antibodies to human NTPDase2 including a blocking antibody.Identification of the ectonucleotidases expressed in mouse, rat, and human Langerhans islets: potential role of NTPDase3 in insulin secretion.8-BuS-ATP derivatives as specific NTPDase1 inhibitors.Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women.Characterization of ecto-nucleotidases in human oviducts with an improved approach simultaneously identifying protein expression and in situ enzyme activity.Ectonucleotidase inhibitors: a patent review (2011-2016).
P2860
Q27000756-3B52ED8F-A1DC-4473-A5DD-6E8C04E09100Q33916983-FC19FD76-D887-4EF4-AED9-7728259D0A90Q34060940-87C030C7-77F9-4C65-9713-F787C0159B6BQ34152663-9562A190-B5A8-4BF7-8460-A30E2E3763B7Q37189598-BC09C073-365E-4A32-B002-A05DB3B38572Q37427521-E3C95038-77B5-4E63-84C9-B798927BFAE8Q37686003-28F28E77-19ED-4537-9FC4-94BF2816A83BQ38110513-24F555D9-9C04-4354-AD66-5DD79EDEABE7Q38151635-FFE545C2-AD3A-423B-829A-8BD9F69051AAQ38730454-75DECCAE-6382-40FF-A6DC-6313EE59C0ECQ39671882-CC022586-D45F-4E41-BE83-3D5FAF95D196Q39989919-CDAF3243-C411-4617-AF01-EE5C813EE285Q44503709-AC88F183-C298-4C53-BE57-4C75E0F8A976Q47259226-4C3ACEAF-A2CC-496E-9F40-0CD57CB079C8Q50224587-07903482-5DDB-4EE0-8307-E4E67AA7B76D
P2860
Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3 : partial characterization of the inhibitory epitope and potential applications
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Characterization of a monoclon ...... ope and potential applications
@ast
Characterization of a monoclon ...... ope and potential applications
@en
type
label
Characterization of a monoclon ...... ope and potential applications
@ast
Characterization of a monoclon ...... ope and potential applications
@en
prefLabel
Characterization of a monoclon ...... ope and potential applications
@ast
Characterization of a monoclon ...... ope and potential applications
@en
P2093
P2860
P1433
P1476
Characterization of a monoclon ...... ope and potential applications
@en
P2093
Alain Tremblay
Beat Künzli
Jean Sévigny
Julie Pelletier
Mercedes N Munkonda
Michel Fausther
Terence L Kirley
Vasily V Ivanenkov
P2860
P304
P356
10.1111/J.1742-4658.2008.06797.X
P407
P577
2009-01-01T00:00:00Z